1855321

Source:http://linkedlifedata.com/resource/pubmed/id/1855321

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0012544, umls-concept:C0020437, umls-concept:C0030705, umls-concept:C0043603, umls-concept:C0087111, umls-concept:C0341697, umls-concept:C0947611, umls-concept:C1524063, umls-concept:C2267018
pubmed:issue	4
pubmed:dateCreated	1991-8-29
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/1855321-2268980
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0364441
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Diphosphonates, http://linkedlifedata.com/resource/pubmed/chemical/pamidronate
pubmed:status	MEDLINE
pubmed:month	Apr
pubmed:issn	0301-0430
pubmed:author	pubmed-author:CunninghamJJ, pubmed-author:KwanJ TJT
pubmed:issnType	Print
pubmed:volume	35
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	182
pubmed:dateRevised	2006-3-8
pubmed:meshHeading	pubmed-meshheading:1855321-Diphosphonates, pubmed-meshheading:1855321-Humans, pubmed-meshheading:1855321-Hypercalcemia, pubmed-meshheading:1855321-Renal Dialysis
pubmed:year	1991
pubmed:articleTitle	Comment on "Use of aminohydroxypropylidene bisphosphonate (AHPrBP, "APD") for the treatment of hypercalcemia in patients with renal impairment" by Yap et al.
pubmed:publicationType	Letter, Comment